Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,867 | 14,691 | 4,999 | 8,740 | 4,680 |
| Marketable Securities | 62,822 | 59,716 | 39,213 | 43,224 | 36,971 |
| Receivables | 32 | 86 | 79 | 75 | 70 |
| TOTAL | $66,944 | $75,780 | $45,491 | $54,407 | $42,921 |
| Non-Current Assets | |||||
| PPE Net | 221 | 249 | 165 | 151 | 171 |
| Investments And Advances | 11,530 | 11,794 | 12,058 | 12,540 | 15,187 |
| Other Non-Current Assets | 1,779 | 1,638 | 1,724 | 1,809 | 536 |
| TOTAL | $13,530 | $13,681 | $13,947 | $14,500 | $15,894 |
| Total Assets | $80,474 | $89,461 | $59,438 | $68,907 | $58,815 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,974 | 3,137 | 1,308 | 2,582 | 1,873 |
| Accrued Expenses | 5,721 | 5,013 | 3,871 | 3,725 | 4,215 |
| Other current liabilities | N/A | N/A | 3,781 | 28,910 | 39,964 |
| TOTAL | $8,074 | $8,505 | $9,279 | $35,402 | $46,406 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 632 | 728 | 834 | 937 | 0 |
| TOTAL | $632 | $728 | $834 | $937 | $N/A |
| Total Liabilities | $8,706 | $9,233 | $10,113 | $36,339 | $46,406 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,682 | 74,514 | 77,115 | 68,136 | 64,257 |
| Common Shares | 7 | 7 | 7 | 7 | 6 |
| Retained earnings | -399,972 | -389,815 | -381,817 | -397,010 | -384,897 |
| Other shareholders' equity | -1,060 | -1,148 | -1,254 | -1,288 | -738 |
| TOTAL | $71,768 | $80,228 | $49,325 | $32,568 | $12,409 |
| Total Liabilities And Equity | $80,474 | $89,461 | $59,438 | $68,907 | $58,815 |